Skip to main content
Celon Pharma S.A. logo

Celon Pharma S.A. — Investor Relations & Filings

Ticker · CLN ISIN · PLCLNPH00015 LEI · 259400Q0ERJT0NC5DT24 WAR Manufacturing
Open in API
Filings indexed 709 across all filing types
Latest filing 2016-10-26 Regulatory Filings
Country PL Poland
Listing WAR CLN

About Celon Pharma S.A.

https://celonpharma.com/en/

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Recent filings

Filing Released Lang Actions
Korekta numeracji raportu bieżącego z dnia 24 października 2016 r. - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short notification from the Management Board ('Zarząd') of Celon Pharma S.A. It explicitly states that a previous current report ('raport bieżący') from October 24, 2016, contained a typographical error regarding its report number (mistakenly numbered 7/2016 instead of 8/2016). This is a correction or clarification regarding a prior regulatory filing concerning a transaction in the company's shares. Since it is a brief announcement correcting a previous filing number, and it doesn't contain the full details of the transaction itself (which would likely be DIRS or POS), nor is it a general announcement of a report's publication (RPA), it fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory correction/clarification.
2016-10-26 Polish
Powiadomienie o transakcji dotyczącej akcji Celon Pharma S.A.
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction (Kupno/Buy) of shares in Celon Pharma S.A. by a member of the Supervisory Board (Artur Wieczorek). This structure—reporting personal share transactions by directors and executives—directly corresponds to the definition of Director's Dealing (insider trades). This matches the definition for 'Director's Dealing' (Code: DIRS). It is not an earnings release, annual report, or general regulatory filing, but a specific disclosure about insider trading.
2016-10-24 Polish
Powiadomienie o transakcji dotyczącej akcji Celon Pharma S.A. - Content (PL)
Director's Dealing Classification · 99% confidence The document text is very short (272 characters) and explicitly states that the management board received a notification from Mr. Artur Wieczorek, a member of the Supervisory Board, regarding a transaction involving company shares. It further states that the notification of the transaction is an attachment to a current report. This content directly relates to insider trading or director/executive share transactions. The most specific category for reporting personal share transactions by directors and executives is 'Director's Dealing' (DIRS). Although it mentions the notification is an attachment to a current report, the core subject matter is the director's dealing, making DIRS the primary classification over a general RPA or RNS.
2016-10-24 Polish
Notyfikacja_Glatton.pdf
Director's Dealing Classification · 98% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) specifically deals with notifications of transactions conducted by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. The content details a transaction involving shares of Celon Pharma S.A. by an associated person ('Glatton Sp. z o.o.'). This clearly indicates an insider transaction report. Among the provided codes, 'DIRS' (Director's Dealing) is the most appropriate category for reporting personal share transactions by directors and executives (insider trades), even if the reporting entity here is an associated person.
2016-10-18 Polish
Powiadomienie o transakcji dotyczącej akcji Celon Pharma S.A. - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (313 characters) and reports that the Management Board of Celon Pharma S.A. received a notification on October 18, 2016, regarding a transaction involving the company's shares by a person closely associated with the CEO (Maciej Wieczorek). This content directly describes a report of personal share transactions by company directors or executives (insider trades). This aligns perfectly with the definition of 'Director's Dealing' (Code: DIRS). The short length suggests it is an announcement/notification rather than the full regulatory filing itself, but DIRS is the most specific category for the content described.
2016-10-18 Polish
Termin publikacji raportu okresowego za III kwartał 2016 roku - Content (PL)
Report Publication Announcement Classification · 98% confidence The document text is very short (293 characters) and is written in Polish. The key phrase is: "Zarząd Celon Pharma S.A.informuje, że raport okresowy za III kwartał 2016 r. zostanie przekazany do wiadomości publicznej w dniu 29 listopada 2016 r." This translates to: "The Management Board of Celon Pharma S.A. informs that the periodic report for the third quarter of 2016 will be made public on November 29, 2016." This is an announcement about the future publication date of a periodic report (Q3 2016). According to Rule #2 (The 'Menu vs Meal' Rule), a short announcement stating that a report will be published fits the definition of a Report Publication Announcement (RPA). It is not the report itself (which would be an IR).
2016-10-18 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.